Standards of care for Kasabach-Merritt phenomenon in China
- PMID: 32851561
- DOI: 10.1007/s12519-020-00379-9
Standards of care for Kasabach-Merritt phenomenon in China
Abstract
Kasabach-Merritt phenomenon (KMP) is a rare disease that is characterized by severe thrombocytopenia and consumptive coagulation dysfunction caused by kaposiform hemangioendothelioma or tufted hemangioma. This condition primarily occurs in infants and young children, usually with acute onset and rapid progression. This review article introduced standardized recommendations for the pathogenesis, clinical manifestation, diagnostic methods and treatment process of KMP in China, which can be used as a reference for clinical practice.
Keywords: Kaposiform hemangioendothelioma; Kasabach−Merritt phenomenon; Tufted hemangioma.
References
-
- Kasabach HH, Merritt KK. Capillary hemangioma with extensive purpura: report of a case. Arch Pediatr Adolesc Med. 1940;59:1063–70.
-
- Zukerberg LR, Nickoloff BJ, Weiss SW. Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Path. 1993;17:321–8. - PubMed
-
- Enjolras O, Wassef M, Mazoyer E, Frieden IJ, Rieu PN, Drouet L, et al. Infants with Kasabach-Merritt syndrome do not have “true” hemangiomas. J Pediatr. 1997;130:631–40. - PubMed
-
- Sarkar M, Mulliken JB, Kozakewich HP, Robertson RL, Burrows PE. Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg. 1997;100:1377–86. - PubMed
-
- Sun YH, Che ZG, Zheng JW. 2018 newly revised ISSVA classification for vascular anomalies. China J Oral Maxillofac Surg. 2019;17:13–9 (in Chinese).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources